Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Journal of Cardiovascular Pharmacology
|
April 1, 1987
Pharmacology of LY195115, a potent, orally active cardiotonic with a long duration of action
J S Hayes, G D Pollock, H Wilson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1985
Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities
J S Hayes, G D Pollock, H Wilson, et al.
Circulation Research
|
September 1, 1977
The effect of dobutamine on cardiac oxygen balance, regional blood flow, and infarction severity after coronary artery narrowing in dogs
R R Tuttle, G D Pollock, G Todd, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1981
Alpha and beta adrenergic effects of the stereoisomers of dobutamine
R R Ruffolo, T A Spradlin, G D Pollock, et al.
Analytical Biochemistry
|
September 1, 1975
A method for counting six gamma nuclides simultaneously in a three channel counter
H W Culp, W D Daniels, D J Pieper, et al.
Journal of Medicinal Chemistry
|
May 1, 1987
Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5'-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)spiro[cycloalkane- 1,3'-[3H]indol]-2'(1'H)-ones
D W Robertson, J H Krushinski, G D Pollock, et al.
Journal of Medicinal Chemistry
|
April 1, 1987
Molecular structure of the dihydropyridazinone cardiotonic 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-pyridazinyl)- 2H-indol-2-one, a potent inhibitor of cyclic AMP phosphodiesterase
D W Robertson, N D Jones, J H Krushinski, et al.
Journal of Medicinal Chemistry
|
June 1, 1985
Structure-activity relationships of arylimidazopyridine cardiotonics: discovery and inotropic activity of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-c]pyridine
D W Robertson, E E Beedle, J H Krushinski, et al.
Journal of Medicinal Chemistry
|
October 1, 1986
Dihydropyridazinone cardiotonics: the discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H -indol-2- one
D W Robertson, J H Krushinski, E E Beedle, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Journal of Cardiovascular Pharmacology
|
April 1, 1987
Pharmacology of LY195115, a potent, orally active cardiotonic with a long duration of action
J S Hayes, G D Pollock, H Wilson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1985
Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities
J S Hayes, G D Pollock, H Wilson, et al.
Circulation Research
|
September 1, 1977
The effect of dobutamine on cardiac oxygen balance, regional blood flow, and infarction severity after coronary artery narrowing in dogs
R R Tuttle, G D Pollock, G Todd, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1981
Alpha and beta adrenergic effects of the stereoisomers of dobutamine
R R Ruffolo, T A Spradlin, G D Pollock, et al.
Analytical Biochemistry
|
September 1, 1975
A method for counting six gamma nuclides simultaneously in a three channel counter
H W Culp, W D Daniels, D J Pieper, et al.
Journal of Medicinal Chemistry
|
May 1, 1987
Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5'-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)spiro[cycloalkane- 1,3'-[3H]indol]-2'(1'H)-ones
D W Robertson, J H Krushinski, G D Pollock, et al.
Journal of Medicinal Chemistry
|
April 1, 1987
Molecular structure of the dihydropyridazinone cardiotonic 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-pyridazinyl)- 2H-indol-2-one, a potent inhibitor of cyclic AMP phosphodiesterase
D W Robertson, N D Jones, J H Krushinski, et al.
Journal of Medicinal Chemistry
|
June 1, 1985
Structure-activity relationships of arylimidazopyridine cardiotonics: discovery and inotropic activity of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-c]pyridine
D W Robertson, E E Beedle, J H Krushinski, et al.
Journal of Medicinal Chemistry
|
October 1, 1986
Dihydropyridazinone cardiotonics: the discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H -indol-2- one
D W Robertson, J H Krushinski, E E Beedle, et al.
Page
of 2